Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jan 20:12:30.
doi: 10.1186/1471-2407-12-30.

Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review

Susanne Hartwig  1 , Stina Syrjänen, Géraldine Dominiak-Felden, Maria Brotons, Xavier Castellsagué
Affiliations
Review

Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review

Susanne Hartwig et al. BMC Cancer. .

Abstract

Background: The role of human papillomavirus (HPV) in malignant and non-malignant genital diseases in women is well known and the corresponding epidemiological burden has been widely described. However, less is known about the role of HPV in anal, penile and head and neck cancer, and the burden of malignant and non-malignant HPV-related diseases in men. The objective of this review is to estimate the epidemiological burden of HPV-related cancers and non-malignant diseases in men in Europe.

Methods: The annual number of new HPV-related cancers in men in Europe was estimated using Eurostat population data and applying cancer incidence rates published by the International Agency for Research on Cancer. The number of cancer cases attributable to HPV, and specifically to HPV16/18, was calculated based on the most relevant prevalence estimates. The annual number of new cases of genital warts was calculated from the most robust European studies; and latest HPV6/11 prevalence estimates were then applied. A literature review was also performed to retrieve exhaustive data on HPV infection at all anatomical sites under study, as well as incidence and prevalence of external genital warts, recurrent respiratory papillomatosis and HPV-related cancer trends in men in Europe.

Results: A total of 72, 694 new cancer cases at HPV-related anatomical sites were estimated to occur each year in men in Europe. 17,403 of these cancer cases could be attributable to HPV, with 15,497 of them specifically attributable to HPV16/18. In addition, between 286,682 and 325,722 new cases of genital warts attributable to HPV6/11were estimated to occur annually in men in Europe.

Conclusions: The overall estimated epidemiological burden of HPV-related cancers and non-malignant diseases is high in men in Europe. Approximately 30% of all new cancer cases attributable to HPV16/18 that occur yearly in Europe were estimated to occur in men. As in women, the vast majority of HPV-positive cancer in men is related to HPV16/18, while almost all HPV-related non-malignant diseases are due to HPV6/11. A substantial number of these malignant and non-malignant diseases may potentially be prevented by quadrivalent HPV vaccination.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Incidence of head and neck cancers, irrespective of HPV status, in men in Europe by age group.
Figure 2
Figure 2
Age-standardised incidence rate (ASR) of a subset of head and neck cancers irrespective of human papillomavirus status.
Figure 3
Figure 3
Distribution of head and neck cancers by anatomical site in men in Europe. a. Distribution of head and neck cancers by anatomical site in men in countries where cancer of the oral cavity is predominant. b. Distribution of head and neck cancers by anatomical site in countries where oropharyngeal cancer is predominant. c. Distribution of head and neck cancers by anatomical site in countries where laryngeal cancer is predominant. ASR age standardised incidence rate.
Figure 4
Figure 4
Age-standardised incidence rate (ASR) of anal cancer irrespective of human papillomavirus status in men in Europe.
Figure 5
Figure 5
Age-standardised incidence rate (ASR) of penile cancer irrespective of human papillomavirus status in men in Europe.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kjaer SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer. 2008;123:1864–1870. doi: 10.1002/ijc.23712. - DOI - PubMed
    1. HPV and cervical cancer in the 2007 report. Vaccine. 2007;25 Suppl 3:C1–230. C1-230. - PubMed
    1. Arbyn M, Castellsague X, deSanjose S, Bruni L, Saraiya M, Bray F. et al.Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22:2675–2686. doi: 10.1093/annonc/mdr015. - DOI - PubMed
    1. Kjaer SK, Tran TN, Sparen P, Tryggvadottir L, Munk C, Dasbach E. et al.The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis. 2007;196:1447–1454. doi: 10.1086/522863. - DOI - PubMed
    1. Roteli-Martins CM, de Carvalho NS, Naud P, Teixeira J, Borba P, Derchain S. et al.Prevalence of human papillomavirus infection and associated risk factors in young women in Brazil, Canada, and the United States: a multicenter cross-sectional study. Int J Gynecol Pathol. 2011;30:173–184. - PubMed